ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 618857 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 618857; 2) Community: the network communities that were significantly associated with the response to NSC 618857; 3) Molecule: the relationships between components within communities and NSC 618857; 4) MDR: the compounds that were significantly associated with the NSC 618857.

NSC Compound Enrichment Correlation
NSC 678106 Rhamnazin 0.00928777138079769 0.27937103
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.00928777138079769 0.055464646
NSC 701022 Null 0.00928777138079769 0.21839335
NSC 701102 2H-1-Benzopyran-2-one, 6-chloro-3-[6-chloroimidazo[1,2-a]pyridin-2-yl]- 0.00928777138079769 -0.11292616
NSC 109451 Null 0.0107933723273943 0.37262571
NSC 12097 Resorufine 0.0107933723273943 -0.12014154
NSC 150311 2-Propenone, 1-(4-bromophenyl)-2-(4-morpholinylmethyl)-3-phenyl-, hydrobromide, (Z)- 0.0107933723273943 -0.23255709
NSC 278631 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- 0.0107933723273943 -0.10273219
NSC 295501 Camptothecin Derivative 0.0107933723273943 0.30330643
NSC 623794 1,4-Benzodioxin-2-carboxamide, 6-(4-oxo-4-H-1- benzopyran-2-yl)-N-(3-pyridinylmethyl)- 0.0107933723273943 0.39883786
Total:60  Current:13    [First] [Prev] [Next] [Last]